Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /3164

GenMont Biotech InCorp.

3164

• TWSE: 3164 • Delayed

17.70TWD -0.3%

0.5608 USD

As of 9 June 2026, GenMont Biotech InCorp. has a market cap of $48.35M USD, ranking #30801 globally and #1857 in Taiwan. It ranks #2779 in the Healthcare sector, and #162 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

30801

Country Rank

1857

Sector Rank

2779

Industry Rank

162

Key Stats

Market Cap

$48.35MUSD

1.53B TWD

Enterprise Value

$44.06MUSD

1.39B TWD

Revenue (TTM)

$12.71MUSD

401.23M TWD

EBITDA (TTM)

$3.82MUSD

120.57M TWD

Net Income (TTM)

$1.81MUSD

57.2M TWD

EBITDA Margin

30%

Profit Margin

14%

PE Ratio

26.9

PS Ratio

3.8

PB Ratio

1.1

EV/EBITDA

11.2

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Founded

2000

Website

genmont.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.3%	-0.8%	-4.1%	-3.8%	-5.3%	-3.3%	-7.8%	-28%	-26%

News

Markets

Exchange	Ticker	Price	Quotes
Taiwan Stock Exchange (TWSE) MIC: XTAI PRIMARY	3164 景岳生物科技股份有限公司 ISIN: TW0003164000 Shares Out.: Shares Outstanding: 86.01M¹ Shares Float: 80.052M² TV: TradingView: TWSE: 3164 SA: Stock Analysis: TPE: 3164 YF: Yahoo Finance: 3164.TW GF: Google Finance: TPE: 3164 BA: Barron's: 3164 MS: Morningstar: XTAI: 3164	17.70 TWD	TV: TradingView: TWSE: 3164 SA: Stock Analysis: TPE: 3164 YF: Yahoo Finance: 3164.TW GF: Google Finance: TPE: 3164 BA: Barron's: 3164 MS: Morningstar: XTAI: 3164

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About GenMont Biotech InCorp.

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Bora Pharmaceuticals Co., Ltd. TWSE: 6472	$1.68B 52.95B TWD 3K%	17.9	Taiwan
Grape King Bio Ltd. TWSE: 1707	$534.8M 16.89B TWD 1K%	14.0	Taiwan
Daiken Biomedical Co., Ltd. TWSE: 7780	$474.56M 14.99B TWD 882%	36.5	Taiwan
TCI Co., Ltd. TPEX: 8436	$413.48M 13.06B TWD 755%	13.7	Taiwan
Microbio Co., Ltd. TPEX: 4128	$290.57M 9.18B TWD 501%	-	Taiwan
Intelligene Inc. TPEX: 7832	$243.37M 7.69B TWD 403%	-	Taiwan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.17B 108.92B ILS 77K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 61K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 33K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 23K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 23K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 19K%	80.6	China

chevron_leftBack